Pin E

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.

Blixt L, Gao Y, Wullimann D, ..., Hansson L, Österborg A

Blood 140 (22) 2403-2407 [2022-12-01; online 2022-09-24]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Funder: VR Type: Journal article

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals

Healy K, Pin E, Chen P, ..., Aleman S, Sällberg Chen M

Med (N Y) - (-) - [2022-01-00; online 2022-01-00]

Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab Funder: VR Research Area: Vaccine Type: Journal article

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C

J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.

Hober S, Hellström C, Olofsson J, ..., Hedhammar M, Nilsson P

Clin Transl Immunol 10 (7) e1312 [2021-07-19; online 2021-07-19]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article